Advances in Dermatology and Allergology
facebook
eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Ethical standards and procedures Reviewers Instructions for authors Publication charge
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
2/2026
vol. 43
 
Share:
Send email
Share:
Original paper

Assessment of the effectiveness of two-year rehabilitation on the functioning of patients with systemic sclerosis

Joanna Łuczak
1
,
Michał Szczerba
2
,
Elżbieta Szymańska
2
,
Joanna Jarosz-Popek
2
,
Anna Czaplicka
2
,
Irena Walecka
2

  1. Centre for Therapeutic Rehabilitation, State Medical Institute of the Ministry of the Interior and Administration (PIM MSWiA), Warsaw, Poland
  2. Department of Dermatology, State Medical Institute of the Ministry of the Interior and Administration (PIM MSWiA), Warsaw, Poland
Adv Dermatol Allergol 2026; XLIII (2): 144–149
DOI: https://doi.org/10.5114/ada.2026.161020
Online publish date: 2026/04/09
Article file
- Assessment of the effectiveness.pdf  [0.18 MB]
Get citation
 
 
1. Lepri G, Di Battista M, Codullo W, et al. Systemic sclerosis: one year in review 2024. Clin Exp Rheumatol 2024; 42: 1517-28.
2. Kanecki K, Goryñski P, Tarka P, et al. Incidence and pre­valence of systemic sclerosis (SSc) in Poland – differences between rural and urban regions. Ann Agric Environ Med 2017; 24: 240-4.
3. de Sousa Paiva Duarte F, da Nobrega Ferreira I, Dos Santos Beserra A, et al. Hand functional capacity in women with systemic sclerosis using the Glittre-ADL-Shelf test: relationship with demographics, body composition, hand function, physical function, digital dexterity, muscle strength and lung function. J Scleroderma Relat Disord 2025; 22: 23971983251341515.
4. Zhao M, Wu J, Wu H, et al. Clinical treatment options in scleroderma: recommendations and comprehensive review. Clin Rev Allergy Immunol 2022; 62: 273-91.
5. Pope JE, Denton CP, Johnson SR, et al. State-of-the-art evidence in the treatment of systemic sclerosis. Nat Rev Rheumatol 2023; 19: 212-26.
6. Jerjen R, Nikpour M, Krieg T, et al. Systemic sclerosis in adults. Part II: management and therapeutics. Am Acad Dermatol 2023; 62: 1877-86.
7. Cornu F, Dechoux C, Etude comparative des possibilites de mobilisation de la mandibule dans les trois plans de l’espace, effectue a partir d’une population examine au centre de Medecine Preventive de Vandoeuvre. These de Doctorat en Chirurgie Dentaire. Nancy 1982.
8. Saunders P, Tsipouri V, Keir GJ, et al. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial. Trials 2022; 87: 957-78.
9. Rahaghi FF, Hsu VM, Kaner RJ, et al. Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respir Res 2023; 24: 6.
10. Roofeh D, Brown KK, Kazeroni EA, et al. Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease. Rheumatology 2023; 62: 1877-86.
11. Mêtel S, Kostrzon M, Adamiak J. Dynamic balance and chest mobility of older adults after speleotherapy combined with pulmonary rehabilitation, endurance and strength training-a prospective study in chronic respiratory diseases. Int J Environ Res Public Health 2022; 19: 11760.
12. Rizzi M, Radovanovic D, Santus P, et al. Usefulness of six-minute walk test in systemic sclerosis. Clin Exp Rheumatol 2018; 36 Suppl 113: 161-7.
13. de Oliveira Saraiva NA, de Oliveira I, Mesquita Dos Santos B, et al. Reference value for the 6-min walking distance in women with systemic sclerosis considering the impact of muscle strength. Clin Biomech 2023; 109: 106094.
14. Jung SM, Park KS, Kim KJ. Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease. Ann Rheum Dis 2022; 81: 108-16.
15. Humbert M, Singh M, Furst DE, et al. Pulmonary hypertension related to systemic sclerosis: points to consider for clinical trials. Bol Med Hosp Infant Mex 2021; 78: 385-94.
16. Badesch DB, McLaughlin VV, Decriox M, et al. Prostanoid therapy for pulmonary arterial hypertension. Rheumatology 2022; 61: 3132-48.
17. Valentini G, Iudici M, Walker UA, et al. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis 2017; 76: 270-6.
18. Tüfekçi O, Ünal E, Aktaş BE, et al. Do functionality, strength, vascularization, inflammatory and biopsychosocial status improve by biopsychosocial model-based exercise in SSc? Rheumatology 2025; 64: 1940-8.
19. Sandqvist G, Nilsson JA, Wuttge DM, et al. Development of a modified hand mobility in scleroderma (HAMIS) test and its potential as an outcome measure in systemic sclerosis. J Rheumatol 2014; 41: 2186-92.
20. Sandqvist G, Eklund M, Hand Mobility in Scleroderma (HAMIS) test: the reliability of a novel hand function test. Arthritis Care Res 2000; 13: 369-74.
21. MacIntosh RB, Shivapuja PK, Naqvi R, Scleroderma and the temporomandibular joint: reconstruction in 2 variants. J Oral Maxillofac Surg 2015; 73: 1199-210.
22. Mehra P, Nadershah M, Chigurupati R. Is alloplastic temporomandibular joint reconstruction a viable option in the surgical management of adult patients with idiopathic condylar resorption? J Oral Maxillofac Surg 2016; 74: 2044-54.
23. Almeida LE, Zammuto S, Mercuri LG. Quality of life outcomes following total temporomandibular joint replacement: a systematic review of long-term efficacy, functional improvements, and complication rates across prosthesis types. J Clin Med 2025; 14: 4859.
24. Ravelo V, Vargas E, Guevara HG, et al. TMJ replacement in degenerative disease: a systematic review. J Clin Med 2025; 14: 580.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2026 Termedia Sp. z o.o.
Developed by Termedia.